1	Flow	_	NN	_	_	3	NMOD	_	_
2	cytometric	_	JJ	_	_	3	NMOD	_	_
3	analysis	_	NN	_	_	0	ROOT	_	_
4	of	_	IN	_	_	3	NMOD	_	_
5	Foxp3	_	NN	_	_	7	NMOD	_	_
6	protein	_	NN	_	_	7	NMOD	_	_
7	expression	_	NN	_	_	4	PMOD	_	_
8	.	_	.	_	_	3	P	_	_
		
1	Cryopreserved	_	JJ	_	_	2	NMOD	_	_
2	PBMCs	_	NNS	_	_	9	VMOD	_	_
3	from	_	IN	_	_	2	NMOD	_	_
4	HAM/TSP	_	JJ	_	_	5	NMOD	_	_
5	patients	_	NNS	_	_	3	PMOD	_	_
6	or	_	CC	_	_	5	COORD	_	_
7	HTLV-I-infected	_	JJ	_	_	8	NMOD	_	_
8	ACs	_	NNS	_	_	6	CONJ	_	_
9	were	_	VBD	_	_	0	ROOT	_	_
10	thawed	_	VBN	_	_	9	VC	_	_
11	and	_	CC	_	_	10	COORD	_	_
12	washed	_	VBN	_	_	11	CONJ	_	_
13	with	_	IN	_	_	12	VMOD	_	_
14	FACS	_	NN	_	_	15	NMOD	_	_
15	buffer	_	NN	_	_	13	PMOD	_	_
16	(	_	(	_	_	18	P	_	_
17	1x	_	JJ	_	_	18	NMOD	_	_
18	PBS	_	NN	_	_	15	PRN	_	_
19	,	_	,	_	_	18	P	_	_
20	0.1	_	CD	_	_	21	AMOD	_	_
21	%	_	NN	_	_	22	NMOD	_	_
22	NaN3	_	NN	_	_	18	COORD	_	_
23	,	_	,	_	_	22	P	_	_
24	5	_	CD	_	_	25	AMOD	_	_
25	%	_	NN	_	_	26	NMOD	_	_
26	FBS	_	NN	_	_	22	COORD	_	_
27	)	_	)	_	_	18	P	_	_
28	.	_	.	_	_	9	P	_	_
		
1	Cells	_	NNS	_	_	7	VMOD	_	_
2	(	_	(	_	_	1	PRN	_	_
3	1.5	_	CD	_	_	2	DEP	_	_
4	x	_	CC	_	_	3	COORD	_	_
5	106	_	CD	_	_	4	CONJ	_	_
6	)	_	)	_	_	2	P	_	_
7	were	_	VBD	_	_	0	ROOT	_	_
8	fixed	_	JJ	_	_	7	VMOD	_	_
9	by	_	IN	_	_	7	VMOD	_	_
10	sequential	_	JJ	_	_	12	NMOD	_	_
11	formaldehyde/methanol	_	NN	_	_	12	NMOD	_	_
12	fixation	_	NN	_	_	9	PMOD	_	_
13	as	_	IN	_	_	7	VMOD	_	_
14	follows	_	VBZ	_	_	13	SUB	_	_
15	.	_	.	_	_	7	P	_	_
		
1	Cells	_	NNS	_	_	2	VMOD	_	_
2	were	_	VBD	_	_	0	ROOT	_	_
3	carefully	_	RB	_	_	2	VMOD	_	_
4	resuspended	_	VBN	_	_	2	VC	_	_
5	in	_	IN	_	_	4	VMOD	_	_
6	FACS	_	NN	_	_	7	NMOD	_	_
7	buffer	_	NN	_	_	5	PMOD	_	_
8	and	_	CC	_	_	7	COORD	_	_
9	fixed	_	JJ	_	_	8	CONJ	_	_
10	with	_	IN	_	_	9	AMOD	_	_
11	100	_	CD	_	_	12	NMOD	_	_
12	mul	_	NN	_	_	10	PMOD	_	_
13	of	_	IN	_	_	12	NMOD	_	_
14	reagent	_	NN	_	_	15	NMOD	_	_
15	A	_	NN	_	_	13	PMOD	_	_
16	(	_	(	_	_	20	P	_	_
17	Fix	_	NN	_	_	20	NMOD	_	_
18	&	_	NN	_	_	20	NMOD	_	_
19	Perm	_	NN	_	_	20	NMOD	_	_
20	kit	_	NN	_	_	15	PRN	_	_
21	;	_	:	_	_	20	P	_	_
22	Caltag	_	NN	_	_	23	NMOD	_	_
23	Laboratories	_	NNS	_	_	20	COORD	_	_
24	,	_	,	_	_	23	P	_	_
25	Burlingame	_	NNP	_	_	27	NAME	_	_
26	,	_	,	_	_	27	P	_	_
27	California	_	NNP	_	_	23	COORD	_	_
28	,	_	,	_	_	27	P	_	_
29	United	_	JJ	_	_	30	NMOD	_	_
30	States	_	NNS	_	_	27	COORD	_	_
31	)	_	)	_	_	20	P	_	_
32	at	_	IN	_	_	15	NMOD	_	_
33	room	_	JJ	_	_	34	NMOD	_	_
34	temperature	_	NN	_	_	32	PMOD	_	_
35	for	_	IN	_	_	15	NMOD	_	_
36	3	_	CD	_	_	37	NMOD	_	_
37	min	_	NN	_	_	35	PMOD	_	_
38	followed	_	VBN	_	_	37	APPO	_	_
39	by	_	IN	_	_	38	VMOD	_	_
40	2	_	CD	_	_	41	NMOD	_	_
41	ml	_	NN	_	_	39	PMOD	_	_
42	of	_	IN	_	_	41	NMOD	_	_
43	70	_	CD	_	_	44	AMOD	_	_
44	%	_	NN	_	_	45	NMOD	_	_
45	methanol	_	NN	_	_	42	PMOD	_	_
46	for	_	IN	_	_	38	VMOD	_	_
47	5	_	CD	_	_	48	NMOD	_	_
48	min	_	NN	_	_	46	PMOD	_	_
49	at	_	IN	_	_	48	NMOD	_	_
50	4	_	CD	_	_	51	NMOD	_	_
51	degreesC	_	NN	_	_	49	PMOD	_	_
52	.	_	.	_	_	2	P	_	_
		
1	Cells	_	NNS	_	_	2	VMOD	_	_
2	were	_	VBD	_	_	0	ROOT	_	_
3	washed	_	VBN	_	_	2	VC	_	_
4	twice	_	RB	_	_	3	VMOD	_	_
5	and	_	CC	_	_	3	VMOD	_	_
6	permeabilized	_	JJ	_	_	7	DEP	_	_
7	with	_	IN	_	_	5	COORD	_	_
8	100	_	CD	_	_	9	NMOD	_	_
9	mul	_	NN	_	_	7	PMOD	_	_
10	of	_	IN	_	_	9	NMOD	_	_
11	reagent	_	NN	_	_	12	NMOD	_	_
12	B	_	NN	_	_	10	PMOD	_	_
13	(	_	(	_	_	17	P	_	_
14	Fix	_	NN	_	_	17	NMOD	_	_
15	&	_	NN	_	_	17	NMOD	_	_
16	Perm	_	NN	_	_	17	NMOD	_	_
17	kit	_	NN	_	_	12	PRN	_	_
18	)	_	)	_	_	17	P	_	_
19	and	_	CC	_	_	3	COORD	_	_
20	stained	_	VBN	_	_	19	CONJ	_	_
21	for	_	IN	_	_	20	VMOD	_	_
22	intracellular	_	JJ	_	_	23	NMOD	_	_
23	Foxp3	_	NN	_	_	21	PMOD	_	_
24	with	_	IN	_	_	20	VMOD	_	_
25	mouse	_	NN	_	_	29	NMOD	_	_
26	anti-human	_	JJ	_	_	29	NMOD	_	_
27	Foxp3	_	NN	_	_	29	NMOD	_	_
28	monoclonal	_	JJ	_	_	29	NMOD	_	_
29	antibody	_	NN	_	_	24	PMOD	_	_
30	(	_	(	_	_	32	P	_	_
31	0.5	_	CD	_	_	32	NMOD	_	_
32	mug	_	NN	_	_	29	PRN	_	_
33	of	_	IN	_	_	32	NMOD	_	_
34	ab22510	_	NN	_	_	33	PMOD	_	_
35	;	_	:	_	_	32	P	_	_
36	Abcam	_	NN	_	_	32	APPO	_	_
37	)	_	)	_	_	32	P	_	_
38	or	_	CC	_	_	29	COORD	_	_
39	the	_	DT	_	_	42	NMOD	_	_
40	appropriate	_	JJ	_	_	42	NMOD	_	_
41	isotype	_	NN	_	_	42	NMOD	_	_
42	control	_	NN	_	_	38	CONJ	_	_
43	for	_	IN	_	_	20	VMOD	_	_
44	30	_	CD	_	_	45	NMOD	_	_
45	min	_	NN	_	_	43	PMOD	_	_
46	.	_	.	_	_	2	P	_	_
		
1	Cells	_	NNS	_	_	2	VMOD	_	_
2	were	_	VBD	_	_	0	ROOT	_	_
3	washed	_	VBN	_	_	2	VC	_	_
4	twice	_	RB	_	_	3	VMOD	_	_
5	and	_	CC	_	_	3	COORD	_	_
6	stained	_	VBN	_	_	5	CONJ	_	_
7	with	_	IN	_	_	6	VMOD	_	_
8	Cy5-conjugated	_	JJ	_	_	14	NMOD	_	_
9	goat	_	NN	_	_	14	NMOD	_	_
10	anti-mouse	_	JJ	_	_	14	NMOD	_	_
11	immunoglobulin	_	NN	_	_	14	NMOD	_	_
12	F(ab')2	_	NN	_	_	14	NMOD	_	_
13	secondary	_	JJ	_	_	14	NMOD	_	_
14	antibody	_	NN	_	_	7	PMOD	_	_
15	(	_	(	_	_	17	P	_	_
16	Caltag	_	NN	_	_	17	NMOD	_	_
17	Laboratories	_	NNS	_	_	14	PRN	_	_
18	)	_	)	_	_	17	P	_	_
19	for	_	IN	_	_	6	VMOD	_	_
20	an	_	DT	_	_	23	NMOD	_	_
21	additional	_	JJ	_	_	23	NMOD	_	_
22	30	_	CD	_	_	23	NMOD	_	_
23	min	_	NN	_	_	19	PMOD	_	_
24	.	_	.	_	_	2	P	_	_
		
1	Cells	_	NNS	_	_	2	VMOD	_	_
2	were	_	VBD	_	_	0	ROOT	_	_
3	washed	_	VBN	_	_	2	VC	_	_
4	twice	_	RB	_	_	3	VMOD	_	_
5	and	_	CC	_	_	3	COORD	_	_
6	stained	_	VBN	_	_	5	CONJ	_	_
7	for	_	IN	_	_	6	VMOD	_	_
8	surface	_	NN	_	_	10	NMOD	_	_
9	CD4	_	NN	_	_	10	NMOD	_	_
10	expression	_	NN	_	_	7	PMOD	_	_
11	with	_	IN	_	_	6	VMOD	_	_
12	PE-labeled	_	JJ	_	_	13	NMOD	_	_
13	anti-CD4	_	JJ	_	_	11	PMOD	_	_
14	(	_	(	_	_	15	P	_	_
15	BD	_	NN	_	_	13	PRN	_	_
16	)	_	)	_	_	15	P	_	_
17	and	_	CC	_	_	13	COORD	_	_
18	CD25	_	NN	_	_	17	CONJ	_	_
19	expression	_	NN	_	_	18	COORD	_	_
20	with	_	IN	_	_	13	NMOD	_	_
21	FITC-labeled	_	JJ	_	_	22	NMOD	_	_
22	anti-CD25	_	NN	_	_	20	PMOD	_	_
23	(	_	(	_	_	24	P	_	_
24	BD	_	NN	_	_	22	PRN	_	_
25	)	_	)	_	_	24	P	_	_
26	.	_	.	_	_	2	P	_	_
		
1	Cells	_	NNS	_	_	2	VMOD	_	_
2	were	_	VBD	_	_	0	ROOT	_	_
3	washed	_	VBN	_	_	2	VC	_	_
4	twice	_	RB	_	_	3	VMOD	_	_
5	and	_	CC	_	_	3	COORD	_	_
6	analyzed	_	VBN	_	_	5	CONJ	_	_
7	on	_	IN	_	_	6	VMOD	_	_
8	a	_	DT	_	_	9	NMOD	_	_
9	FACSCalibur	_	NN	_	_	7	PMOD	_	_
10	(	_	(	_	_	11	P	_	_
11	BD	_	NN	_	_	9	PRN	_	_
12	)	_	)	_	_	11	P	_	_
13	.	_	.	_	_	2	P	_	_
		
1	Data	_	NN	_	_	2	NMOD	_	_
2	analysis	_	NN	_	_	3	VMOD	_	_
3	was	_	VBD	_	_	0	ROOT	_	_
4	performed	_	VBN	_	_	3	VC	_	_
5	using	_	VBG	_	_	4	VMOD	_	_
6	FlowJo	_	NN	_	_	5	VMOD	_	_
7	(	_	(	_	_	9	P	_	_
8	Tree	_	NN	_	_	9	NMOD	_	_
9	Star	_	NN	_	_	6	PRN	_	_
10	,	_	,	_	_	9	P	_	_
11	Ashland	_	NNP	_	_	13	NAME	_	_
12	,	_	,	_	_	13	P	_	_
13	Oregon	_	NNP	_	_	9	APPO	_	_
14	,	_	,	_	_	13	P	_	_
15	United	_	JJ	_	_	16	NMOD	_	_
16	States	_	NNS	_	_	13	NMOD	_	_
17	)	_	)	_	_	9	P	_	_
18	.	_	.	_	_	3	P	_	_
		
